QURE.AI TECHNOLOGIES PRIVATE LIMITED

In their own words

Qure is working towards the automatic interpretation of radiology images to support healthcare systems in the lower income regions of the world where quality radiology reporting may not be available. A lot of our work has been using Artificial Intelligence (AI) towards diagnosis of Tuberculosis. India has the highest number of TB cases - more than 1/4th of the global cases. We are working with several government organizations and NGOs to scale up the screening of Tuberculosis, so that every TB patient can be diagnosed and treated early on during their infection before they infect others around them. Recently, we have extended this capability to the diagnosis of COVID-19 where PCR testing is highly limited and many governments are looking to innovative approaches for diagnosis of COVID-19 using the abundant X-ray capabilities. Qure.ai’s solution helps in triaging and testing the right individuals by detecting presence of COVID-19 on Chest X-rays. We also measure the progression of COVID-19 patients by quantifying the amount of lung infection. Other solutions developed by Qure can instantly detect Trauma or Stroke and help Trauma/Stroke patients get timely care potentially saving millions of lives around the world. Our solutions are also applicable to the developed nations where AI reported radiology scans can help reduce the workload of radiologists and also provide timely care to patients. Our solutions are currently being used in 28 countries and are touching the lives of about 10,000 patients on a daily basis. From the time of inception we have grown to a size of 51 employees and will grow faster as we increase the number of disease conditions we can detect.

Written by the company on its public Startup India profile. Not verified by us.